The K@W Network:
Wharton's Mark Pauly and Genevieve Kanter, a professor at Penn's medical school, discuss potential changes to the rules on preventing physician kick-backs.
Government intervention could work where market mechanisms have failed to keep prescription drug prices affordable – but policymakers will have a tough time cutting through the finger-pointing from all sides,[…]
AI has the potential to boost medical outcomes while lowering costs in the U.S. health care system. In this opinion piece, experts propose one way of implementing AI using a[…]
Prime Minister Narendra Modi has launched the world’s biggest government health insurance program. While some are questioning his motives, experts say it is a necessary step for India.
Do short-term, limited-duration health insurance policies increase consumer choice? Or do they put people in danger of not having adequate coverage if disaster strikes?
A lawsuit that wants to dismantle the Affordable Care Act in its entirety could create outcomes that are worse than the problems it aims to fix.
A one-size-fits-all approach is often the fundamental flaw of these programs, say Wharton and Penn researchers.
Hospitals can cut medical bills and raise the quality of care by bundling up multiple services in one bill, notes new research by Penn medicine's Amol Navathe.
President Trump’s recently announced plan to lower prescription drug prices could benefit consumers in the short run, but it may end up hurting new drug development, experts say.
Is it possible to end all epidemics? Harvard Medical School's Jonathan Quick says there are steps public institutions can -- but don't -- take to protect society.